(Q44757991)

6 December 2017

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease (English)

1 reference

6 December 2017

0 references

Athena Kalyvas

1

1 reference

PubMed ID

14766173

6 December 2017

Samuel David

series ordinal

2

1 reference

PubMed ID

14766173

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

41

1 reference

6 December 2017

323-335

1 reference

6 December 2017

3

1 reference

Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones.

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephal

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

1 reference

7 January 2021

Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Prostaglandin release in multiple sclerosis: correlation with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and beta-actin in quantitative RNA analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A2: structure-function studies with vesicle, micelle, and membrane assays1This paper is dedicated to the memory of Prof. H.M. Verheij.1

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Chemokines in autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Chemokine expression in murine experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

New concepts in the immunopathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Duffy Antigen Facilitates Movement of Chemokine Across the Endothelium In Vitro and Promotes Neutrophil Transmigration In Vitro and In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Inhibition of Monocyte Chemotaxis to C-C Chemokines by Antisense Oligonucleotide for Cytosolic Phospholipase A

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

1 reference

7 January 2021

Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Drug treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Inhibition of autoimmune encephalomyelitis by a tetracycline.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

The chemokine system in neuroinflammation: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Eicosanoids: lipid mediators of inflammation in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Multiple sclerosis treatment 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Lysophosphatidylcholine: a chemoattractant to human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Assessment of animal models for MS and demyelinating disease in the design of rational therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Mechanisms of glutamate release in the rat spinal cord slices during metabolic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

BLT1 and BLT2: the leukotriene B(4) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

NMR structural studies of the tight complex between a trifluoromethyl ketone inhibitor and the 85-kDa human phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Role of cytosolic phospholipase A2 in allergic response and parturition

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Experimental allergic encephalomyelitis-prophylactic and therapeutic treatment with the cyclooxygenase inhibitor piroxicam (Feldene)

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

[On the activity of phospholipase A2 compared with 1-alk-1'-enyl-2-acyl- and 1-alkyl-2-acyl-glycerophosphatides in multiple sclerosis (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2804%2900003-0

7 January 2021

10.1016/S0896-6273(04)00003-0

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

14766173